Partial Lipodystrophy Clinical Trials in Bethesda, Maryland
2 recruitingBethesda, Maryland
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance
Partial LipodystrophyInsulin Receptor Mutation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)25 enrolled1 locationNCT05470504
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
Partial LipodystrophyGeneralised Lipodystrophy
Amryt Pharma100 enrolled28 locationsNCT02325674